196 related articles for article (PubMed ID: 31142231)
1. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
[TBL] [Abstract][Full Text] [Related]
4. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
Rodvold KA; Blum RA
J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
[TBL] [Abstract][Full Text] [Related]
6. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
7. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin monitoring: one or two serum levels?
Andrés I; López R; Pou L; Piñol F; Pascual C
Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
[TBL] [Abstract][Full Text] [Related]
9. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
[TBL] [Abstract][Full Text] [Related]
10. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
11. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
Denaro CP; Ravenscroft PJ
Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
[TBL] [Abstract][Full Text] [Related]
17. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
[TBL] [Abstract][Full Text] [Related]
18. Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin.
Salehpour N; Riley LD; Gonzales MJ; Kobic E; Nix DE
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0017223. PubMed ID: 37133362
[TBL] [Abstract][Full Text] [Related]
19. Predictive performance of a vancomycin-aminoglycoside population model.
Beringer PM; Wong-Beringer A; Rho JP
Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
[TBL] [Abstract][Full Text] [Related]
20. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]